Literature DB >> 2752506

A study of the mechanisms of cytotoxicity of Ara-C on three human leukemic cell lines.

J Zittoun1, J Marquet, J C David, D Maniey, R Zittoun.   

Abstract

The main biochemical determinants involved in cytosine arabinoside (Ara-C) metabolism were studied in one lymphoblastic (Reh) and two myeloid (HL60 and K562) human leukemic cell lines exhibiting various sensitivities to Ara-C, Reh being the most and HL60 the least sensitive. The level of intracellular Ara-C accumulation and Ara-CTP formation was far more important in Reh cells than in myeloid cell lines but was not closely related to deoxycytidine kinase activity or to deoxycytidine triphosphate pool size. The level of Ara-C incorporated into DNA was similar in the three cell lines. Ara-CTP formation correlated better with the cytotoxicity to clonogenic cells than did Ara-C incorporation into DNA. DNA polymerase alpha was moderately inhibited to various degrees, depending on the cell line; this moderate inhibition does not seem sufficient to explain the inhibition of DNA synthesis. The activity of DNA ligase, the enzyme joining the Okazaki fragments, which was not detected in Reh cells, was strongly inhibited by Ara-C in HL60 and to a lesser degree, in K562 cells. The inhibition of DNA ligase probably also contributes to the inhibition of DNA synthesis and, thus, to the cytotoxic effect of Ara-C and may explain the smaller size of DNA fragments observed following Ara-C treatment. The variations in each critical determinant observed in these three cell lines increase the complexity and plurality of the mechanisms of Ara-C action.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2752506     DOI: 10.1007/bf00257628

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  30 in total

1.  DNA ligases during rat liver regeneration.

Authors:  S Söderhäll
Journal:  Nature       Date:  1976-04-15       Impact factor: 49.962

2.  Deoxyribonucleic acid synthesis in mammalian nuclei. Incorporation of deoxyribonucleotides and chain-terminating nucleotide analogues.

Authors:  M A Waqar; L A Burgoyne; M R Atkinson
Journal:  Biochem J       Date:  1971-03       Impact factor: 3.857

3.  Studies in mouse L-cells on the incorporation of 1-beta-D-arabinofuranosylcytosine into DNA and on inhibition of DNA polymerase by 1-beta-D-arabinofuranosylcytosine 5'-triphosphate.

Authors:  F L Graham; G F Whitmore
Journal:  Cancer Res       Date:  1970-11       Impact factor: 12.701

4.  An enzymatic method for the determination of dCTP and dGTP in picomole amounts.

Authors:  L Skoog
Journal:  Eur J Biochem       Date:  1970-12

5.  Studies on the mechanism of action of cytosine arabinoside.

Authors:  D W Kufe; P P Major
Journal:  Med Pediatr Oncol       Date:  1982

6.  DNA repair under stress.

Authors:  R T Johnson; A R Collins; S Squires; A M Mullinger; G C Elliott; C S Downes; I Rasko
Journal:  J Cell Sci Suppl       Date:  1987

7.  DNA ligases in human leukemia.

Authors:  J C David; R Zittoun; T Bassez; D Maniey; R Rusquet; M Bonhommet; P Y Le Prise; D Thevenin; A M Suberville; J P Marie
Journal:  Leuk Res       Date:  1985       Impact factor: 3.156

8.  Studies on 1-beta-D-arabinofuranosyl-cytosine-resistant mutants of Chinese-hamster fibroblasts. A mitochondrial deoxycytidine kinase devoid of activity on arabino-cytosine.

Authors:  B R de Saint-Vincent; G Buttin
Journal:  Eur J Biochem       Date:  1973-09-03

9.  Enzymatic joining of polynucleotides. IX. A simple and rapid assay of polynucleotide joining (ligase) activity by measurement of circle formation from linear deoxyadenylate-deoxythymidylate copolymer.

Authors:  P Modrich; I R Lehman
Journal:  J Biol Chem       Date:  1970-07-25       Impact factor: 5.157

10.  Deoxycytidine preferentially protects normal versus leukemic myeloid progenitor cells from cytosine arabinoside-mediated cytotoxicity.

Authors:  K Bhalla; W MacLaughlin; J Cole; Z Arlin; M Baker; G Graham; S Grant
Journal:  Blood       Date:  1987-08       Impact factor: 22.113

View more
  3 in total

1.  Enhanced Replication of Mouse Adenovirus Type 1 following Virus-Induced Degradation of Protein Kinase R (PKR).

Authors:  Danielle E Goodman; Carla D Pretto; Tomas A Krepostman; Kelly E Carnahan; Katherine R Spindler
Journal:  mBio       Date:  2019-04-23       Impact factor: 7.867

2.  Voreloxin, a first-in-class anticancer quinolone derivative, acts synergistically with cytarabine in vitro and induces bone marrow aplasia in vivo.

Authors:  Caroline D Scatena; Jeffrey L Kumer; Jennifer P Arbitrario; Anthony R Howlett; Rachael E Hawtin; Judith A Fox; Jeffrey A Silverman
Journal:  Cancer Chemother Pharmacol       Date:  2010-01-08       Impact factor: 3.333

3.  Systematic dielectrophoretic analysis of the Ara-C-induced NB4 cell apoptosis combined with gene expression profiling.

Authors:  Yi Lv; Lingqin Zeng; Guanbin Zhang; Youchun Xu; Ying Lu; Keith Mitchelson; Jing Cheng; Wanli Xing
Journal:  Int J Nanomedicine       Date:  2013-06-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.